ABSI:NASDAQ, Absci Corporation

ABSI stock overview

Absci Corporation (ABSI:NASDAQ) closed at $9.18 on October 23, 2026, down 2.03% on the day. The stock trades 23.8% below its 52-week high of $12.06 and 309.8% above its 52-week low of $2.24. Over the past year, it gained 115.0%. Absci Corporation is part of the Health Care sector.

Key figures

Price: $9.18
Day change: -2.03%
Volume: 1,888,993
Average volume: 3,438,434
Market cap: 1B+
52-week range: $2.24 – $12.06
50-day average: $9.34
200-day average: $6.27

Price action over the past year

In 252 trading sessions since October 23, 2025, ABSI closed higher on 125 days (50%). Its best day was June 24, 2026 (+35.96%) and its worst was November 13, 2025 (-22.35%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

Oct 24, 2026: News catalyst: Biotech (News Catalysts scanner)
Oct 6, 2026: Spiked to $11.89 on 5M+ shares (Spikes scanner)

ABSI news

Oct 24, 2026: Is Absci (ABSI) Undervalued As Positive ABS 201 Phase 1 Data Lifts Optimism?
Oct 16, 2026: Absci (ABSI) Stock Seems Rich Against Its Book Value Backdrop
Oct 13, 2026: Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
Oct 7, 2026: Absci (ABSI) Stock Dropped, So What Is Behind The Latest Attention?
Sep 24, 2026: Absci Announces Preliminary Details for Phase 2 STORYLINE Trial of AI-Designed Antibody ABS-201 for Endometriosis
Sep 24, 2026: Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
Sep 22, 2026: Absci (ABSI) Stock Looks Expensive Against Its Book Value
Sep 21, 2026: Recursion Pharmaceuticals Highlights AI Drug Platform, FAP Progress at Morgan Stanley Conference

About Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Similar stocks

Find more stocks like ABSI with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.